Promoting advanced solutions that support globalization and progress in the pharmaceutical industry
The pharmaceutical industry in Japan today faces enormous challenges, such as social security reform, including medical service fees and drug pricing, as well as intensifying competition with pharmaceutical giants based in Europe and North America. Consequently, the trend toward industry-wide reorganization for survival is accelerating.
Therefore, every pharmaceutical company is taking a number of actions, including: strengthening the structure and improving the performance of R&D to expand the pipeline for new medications; reinforcing the efforts of medical representatives (MRs); expanding overseas business; and responding to global regulation.
In response to industry challenges, we have established an optimal system that consists of a team of specialists with ample experience and extensive knowledge of the pharmaceutical industry. Our broad spectrum of solutions ranges from R&D, production, sales, and distribution to personnel and accounting. Moreover, our service network extends overseas to support our customers' international operations as well.
Encompassing all phases of pharmaceutical R&D
CAC provides PRASMA (Pharmaceutical Research Advanced Solutions and Management), which represents a comprehensive solution encompassing all five phases of pharmaceutical R&D, featuring expendability to support the system integration opportunities that may arise in the course of mergers involving domestic and overseas companies, as well as also supporting a high level of security.
Total support for ERP
We offer complete solutions that improve operations by addressing the mission-critical tasks of the pharmaceutical industry, such as management, sales and marketing, and production and distribution. CAC’s proprietary solutions, such as support for MRs and marketing, contribute to strengthening the sales and marketing of pharmaceutical companies.